THERMO FISHER SCIENTIFIC INC (1TMO.MI) Stock Price, Forecast & Analysis

BIT:1TMO • US8835561023

541.3 EUR
+47.3 (+9.57%)
Last: Jan 16, 2026, 07:00 PM

1TMO.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap203.37B
Revenue(TTM)43.74B
Net Income(TTM)6.57B
Shares375.71M
Float375.02M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend1.29
Dividend Yield0.27%
EPS(TTM)19.08
PE28.37
Fwd PE25.57
Earnings (Next)01-29
IPO1980-08-27
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
1TMO.MI short term performance overview.The bars show the price performance of 1TMO.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30 40 50

1TMO.MI long term performance overview.The bars show the price performance of 1TMO.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1TMO.MI is 541.3 EUR. In the past month the price increased by 10.29%.

THERMO FISHER SCIENTIFIC INC / 1TMO Daily stock chart

1TMO.MI Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to 1TMO.MI.


Chartmill TA Rating
Chartmill Setup Rating
1TMO.MI Full Technical Analysis Report

1TMO.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to 1TMO.MI. 1TMO.MI has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
1TMO.MI Full Fundamental Analysis Report

1TMO.MI Financial Highlights

Over the last trailing twelve months 1TMO.MI reported a non-GAAP Earnings per Share(EPS) of 19.08. The EPS increased by 4.53% compared to the year before.


Industry RankSector Rank
PM (TTM) 15.02%
ROA 6.38%
ROE 12.88%
Debt/Equity 0.62
Chartmill High Growth Momentum
EPS Q2Q%9.66%
Sales Q2Q%4.94%
EPS 1Y (TTM)4.53%
Revenue 1Y (TTM)3.22%
1TMO.MI financials

1TMO.MI Forecast & Estimates

32 analysts have analysed 1TMO.MI and the average price target is 571.25 EUR. This implies a price increase of 5.53% is expected in the next year compared to the current price of 541.3.

For the next year, analysts expect an EPS growth of 5.08% and a revenue growth 3.54% for 1TMO.MI


Analysts
Analysts83.13
Price Target571.25 (5.53%)
EPS Next Y5.08%
Revenue Next Year3.54%
1TMO.MI Analyst Estimates1TMO.MI Analyst Ratings

1TMO.MI Ownership

Ownership
Inst Owners92.78%
Ins Owners0.1%
Short Float %N/A
Short RatioN/A
1TMO.MI Ownership

1TMO.MI Competitors/Peers

The largest stocks on the EU markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
SRT3 SARTORIUS AG-VORZUG39.7117.994B
DIM SARTORIUS STEDIM BIOTECH34.3117.821B
56S1 SARTORIUS STEDIM BIOTECH34.117.709B
SRT SARTORIUS AG31.6314.332B
QIA QIAGEN N.V.18.398.644B
1SXP SCHOTT PHARMA AG& CO KGAA13.042.226B
EVT EVOTEC SE N/A2.088B
GXI GERRESHEIMER AG5.65585.453M
FF FINE FOODS & PHARMACEUTICALS16.56256.448M
ALECR EUROFINS CEREP-REGR N/A159M

About 1TMO.MI

Company Profile

1TMO logo image Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. The company is headquartered in Waltham, Massachusetts and currently employs 125,000 full-time employees. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. The company also provides purification and filtration technologies.

Company Info

THERMO FISHER SCIENTIFIC INC

168 Third Avenue

Waltham MASSACHUSETTS US

Employees: 125000

1TMO Company Website

1TMO Investor Relations

Phone: 17816221000

THERMO FISHER SCIENTIFIC INC / 1TMO.MI FAQ

What does THERMO FISHER SCIENTIFIC INC do?

Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. The company is headquartered in Waltham, Massachusetts and currently employs 125,000 full-time employees. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. The company also provides purification and filtration technologies.


What is the current price of 1TMO stock?

The current stock price of 1TMO.MI is 541.3 EUR. The price increased by 9.57% in the last trading session.


What is the dividend status of THERMO FISHER SCIENTIFIC INC?

THERMO FISHER SCIENTIFIC INC (1TMO.MI) has a dividend yield of 0.27%. The yearly dividend amount is currently 1.29.


How is the ChartMill rating for THERMO FISHER SCIENTIFIC INC?

1TMO.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Where is THERMO FISHER SCIENTIFIC INC (1TMO.MI) stock traded?

1TMO.MI stock is listed on the Euronext Milan exchange.


Can you provide the growth outlook for THERMO FISHER SCIENTIFIC INC?

The Revenue of THERMO FISHER SCIENTIFIC INC (1TMO.MI) is expected to grow by 3.54% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.